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Interleukin-9 Expression in Human
Eosinophils
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ABSTRACT
Background: Eosinophils play a pivotal role in allergic inflammation. Recent evidence suggests that they not
only function as terminal effector cells but have potential to interact with allergen and initiate immune re-
sponses. We investigated cytokine production from eosinophils through direct interaction with a major allergen,
house dust mite (HDM) .
Methods: Purified eosinophils from HDM-sensitized or non-sensitized donors were cultured with HDM extract
or lipopolysaccharide (LPS) for 18 or 40 h. A panel of cytokine gene expression in eosinophils was examined
by means of real-time RT-PCR. Released cytokines in the culture supernatants were assessed with a specific
ELISA. In some experiments, HDM was pretreated with protease inhibitors, then added to the culture. Cytoki-
nes tested for gene expression were interleukin (IL)-2, 4, 6, 7, 8, 9, 10, 11, 12, 13, 16,17, 18, TGF-β1 and GM-
CSF,.
Results: LPS induced small enhancement of GM-CSF gene expression at 18 h. At 40 h, HDM induced about
60-fold enhancement of IL-9 gene expression. IL-9 protein was also detected in the culture supernatants at 60
h. Those reactions were observed regardless of HDM sensitization status of the donors. HDM-induced IL-9 ex-
pression was completely inhibited with a serine protease inhibitor, AEBSF, not with a cysteine protease inhibi-
tor, E-64.
Conclusions: Accumulated eosinophils in the airways in asthma may directly react with HDM and produce IL-
9 to further promote Th2-type immune responses. Protease-activated receptor 2, a ligand for serine proteases,
which contained in HDM, may be involved in the reaction.
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INTRODUCTION
Massive eosinophil infiltration in the airway mucosa
is a prominent feature of the pathology of bronchial
asthma and multiple evidence suggest that eosino-
phils are the major effector cells in the pathogenesis
of bronchial hyperresponsiveness and airway remod-
eling in asthma.1 Among various mediators from
eosinophils, major basic protein (MBP) in specific
granules has pleiotropic functions to cause bronchial
epithelial cell damage,2 airway hyperresponsivenss,3
and activation of other inflammatory cells.4 Cysteinyl
leukotrienes cause acute bronchoconstriction, hyper-
secretion, and promote airway inflammation.5 Trans-
forming growth factor β (TGF-β) from eosinophils6
has been shown to be involved in airway remodel-
ing.7
Conventional understanding of the role of eosino-
phils in asthma is the terminal effectors as described
above under control of Th2 cells,8 natural killer T
cells,9 mast cells,10 and monocytes.11 Recent evi-
dence, however, suggests that eosinophils not only
function as terminal effector cells but as immuno-
modulatory cells in innate immunity. Eosinophils in
the airways have a potential to traffic to regional
lymphnodes for antigen presentation to T cells.12,13
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Eosinophil-derived neurotoxin (EDN), one of eosino-
phil granule proteins, induces dendritic cell migra-
tion.14 Eosinophils also directly interacts with aller-
gens; house dust mite (HDM) and birch pollen aller-
gens induce chemotaxis and degranulation,15 pollen-
associated lipid mediators induce chemotaxis and
CD11b expression,16 and an environmental fungus Al-
ternaria protein product induces intracellular calcium
mobilization, cell surface expression of CD63 and
CD11b, and degranulation.17 These observations indi-
cate that eosinophils can initiate or modulate allergic
immune responses by interacting with exogenous
molecules such as allergens.
Thus, to further clarify the potential of eosinophils
as initiators of allergic inflammation, we investigated
a panel of cytokine production from eosinophils
through direct interaction with a major allergen,
HDM. Here, we found that eosinophils produce sig-
nificant amount of IL-9, one of the pivotal Th2-type cy-
tokines in the pathogenesis of asthma, in response to
HDM extract.
METHODS
REAGENTS
House dust mite (Dermatophagoides pteronyssinus)
extract was purchased from GREER Laboratories
(Lenoir, NC, USA). E-coli-derived lipopolysaccharide
(LPS) was from Sigma (St. Louis, MO, USA). Pro-
tease inhibitors, trans-epoxysuccinyl-L-leucylamido
(4-guanidino)-butane (E-64) and 4-(2-Aminoethyl)-
benzenesulfonyl fluoride (AEBSF) were also pur-
chased from Sigma.
ISOLATION OF EOSINOPHILS
Heparinized peripheral blood was obtained from
HDM-sensitized or non-sensitized donors. The for-
mer subjects had mild allergic rhinitis and the latter
were healthy non-atopic individuals. Sensitization to
HDM was defined as CAP-RAST titer to Dermato-
phagoides pteronysmus >0.7 UAml (Phadia, Tokyo,
Japan). Eosinophils were isolated by negative selec-
tion using anti-CD16 bound micromagnetic beads
(MACSTM, Miltenyi Biotec GmbH, Bergisch Glad-
bach, Germany) as previously described.18 The purity
of eosinophils was more than 99%. This work was ap-
proved by the ethical committee of Mie National Hos-
pital and written informed consents were obtained
from all subjects.
QUANTITATIVE RT-PCR
Purified eosinophils at 1 × 106ml in RMPI 1640 me-
dium (Sigma) were cultured with HDM extract at 100
μgml or LPS at 1 μgml in the presence of 5% heat-
inactivated fetal bovine serum (FBS; Sigma) or 5%
non-processed FBS for 18 or 40 h. Total RNA was ex-
tracted from the cells and reverse transcribed. Real-
time PCR was carried out for IL-2, IL-4, IL-6, IL-7, IL-
8, IL-9, IL-10, IL-11, IL-13, IL-17, IL-18, and GM-CSF
on ABI Prism 7700 Sequence Detection System (Ap-
plied Biosystems, Foster City, CA, USA). Probe
primer sets for each cytokine were designed using
Primer Express software (Applied Biosytems). Rela-
tive gene expression was calculated with the 2−∆∆CT
method reported elsewhere.19 In some experiments,
HDM was incubated with a cysteine protease inhibi-
tor, E-64 or a serine protease inhibitor, AEBSF, at
37℃ for 30 min then added to the culture.
ELISA FOR IL-9
Eosinophils at 1 × 106ml in RMPI 1640 medium with
5% FBS in the presence or absence of HDM were cul-
tured for 60 h and the supernatants were tested for
IL-9 protein by a sandwich ELISA. Each well of a 96-
well microplate (Immuno Module F8 Maxisorp,
Nunc, Roskilde, Denmark) was filled with 50 μl of
anti-human IL-9 monoclonal antibody (clone MH9A4,
BioLegend, San Diego, CA, USA) at 5 μgl in carbon-
ate buffer (pH 9.6) and incubated for 18 h at 4℃. Af-
ter removal of the antibody solution, the wells were
washed four times with phosphate-buffered saline
containing 0.5 mll Tween 20 (PBS-T). PBS contain-
ing 0.1% bovine serum albumin (BSA; Sigma) was
added to each well, then incubated for 1 h at 25℃. Af-
ter aspiration, aliquots of human recombinant IL-9
(PeproTech, New Jersey, USA) standards or samples
(25 μl each) were added to the wells and incubated
for 16 h at 4℃. Each well was washed four times with
PBS-T, 50 μl of biotin-conjugated anti-human IL-9
(clone MH9A3, BioLegend) was added and incubated
for 1 h at 25℃. After washing with PBS-T, 100 μl of
streptoavidin-HRP (GIBCO Industries, Langley, OK,
USA) in PBS containing 0.1% BSA was added to each
well and incubated for 1 h at 25℃. Following four
washing of the assay plates, the immunoreactivity
was visualized by addition of 100 μlwell of substrate
solution (TMB solution, Roche Diagnostics GmbH,
Mannheim, Germany) for 15 min at 25℃. The reac-
tion was stopped by the addition of 50 μl of 1 gl so-
dium dodecil sulfate to each well, and absorbance
was measured at 405 nm. The IL-9 levels were calcu-
lated based on the standard curve on each assay
plate.
STATISTICAL ANALYSIS
The data were expressed as mean ± SEM of indicated
numbers of experiments and p values were deter-
mined with ANOVA for multiple groups with Bonfer-
roni post test.
RESULTS
CYTOKINE GENE EXPRESSION OF EOSINO-
PHILS BY HDM EXTRACT AND LPS
First, we tested whether HDM extract directly in-
duces cytokine gene expression from eosinophils.
Because HDM extract may contain LPS and LPS acti-
vates eosinophils via TLR-4 and CD14,20 which is not
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Fig. 1 Cytokine gene expression by HDM extract (open bar), LPS with heat-inactivated 
FBS (horizontal hatched bar), and LPS with non-processed FBS (diagonal hatched bar). 
A. 19 h culture B. 40 h culture. The data represent geometric means of fold changes in 
gene expression. (n＝4―5). ＊p＜0.05
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only expressed on the cell surface but present as sol-
uble form in the serum,21 we also cultured eosino-
phils with LPS in FBS-containing medium. In addi-
tion, to fully induce activation potential of LPS, FBS
with no heat inactivation process was also used since
complements may be involved in LPS-induced activa-
tion.22,23 At 18 h of incubation, HDM extract did not
induce more than 3-fold increase in gene expression
of a panel of cytokine tested (Fig. 1A). LPS in combi-
nation with non-processed serum induced significant
gene expression of GM-CSF (Fig. 1A). At 40 h, sur-
prisingly, HDM induced about 60-fold enhancement
of IL-9 gene expression while LPS did not cause sig-
nificant gene expression of any cytokine (Fig. 1B).
We also confirmed with a specific ELISA that HDM
extract, not LPS, induced significant IL-9 protein pro-
duction at 60 h of incubation (Fig. 2).
HDM EXTRACT INDUCED IL-9 PRODUCTION RE-
GARDLESS OF HDM SENSITIZATION STATUS
Since HDM is a major IgE sensitizing allergen, we
sought the possible relationship between the pres-
ence of HDM-specific IgE antibody and HDM-
induced IL-9 gene expression in the subjects. There
was, however, no difference in IL-9 gene expression
between HDM-sensitized and non-sensitized donors
(Fig. 3).
SERINE PROTEASE INHIBITOR ABOLISHED
HDM-INDUCED IL-9 GENE EXPRESSION
Many allergens including HDM are found to be pro-
teases. We then examined the effect of protease in-
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Fig. 2 IL-9 protein concentrations in the supernatants of 
eosinophils after 60 h of culture with HDM extract (open bar), 
LPS with heat-inactivated FBS (horizontal hatched bar), and 
LPS with non-processed FBS (diagonal hatched bar). The 
data represent geometric means. (n＝3). ＊p＜0.05
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Fig. 3 HDM-induced IL-9 gene expression in HDM-sensi-
tized (HDM-IgE (＋ ) and non-sensitized (HDM-IgE (－ ) 
individuals. We compared the two groups by Man-Whitney 
test. N.S.; not significant
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hibitors to see whether the cytokine-inducing func-
tion of HDM is derived from its proteolytic activity for
protease-activated receptors (PARs) expressed on
eosinophils.24 Pretreatment of HDM with a serine
protease inhibitor, AEBSF, completely abolished the
subsequent IL-9 gene expression with HDM (Fig. 4).
On the other hand, a cysteine protease inhibitor, E-
64, did not have any effect on the reaction even at the
higher concentration. Because of known specificity of
proteases to PAR, it is suggested that eosinophils
may respond to HDM via PAR-2.
DISCUSSION
In the present study, we showed that eosinophils di-
rectly reacted with a major allergen, HDM, and pro-
duced significant amount of a pleiotropic Th2-type cy-
tokine, IL-9. Since the stimulatory effect of HDM was
completely abolished by pretreatment with a serine
protease inhibitor, not with a cysteine protease inhibi-
tor, it is suggested that eosinophils responded to
HDM through PAR-2, at least in part.
IL-9 is classified as a Th2-type cytokine originally
identified in activated CD4+ T cells.25 It promotes the
proliferation and differentiation of mast cells and he-
matopoietic progenitors, stimulates the proliferation
of activated T cells, and enhances the production of
immunoglobulins by B cells.26 In the context of Th2-
type inflammation, IL-9 was reported to induce eo-
taxin production from airway smooth muscle cells, IL-
5 receptor expression from eosinophils,27,28 and gob-
let cell hyperplasia.29 Selective overexpression of the
IL9 gene within the lungs of transgenic mice resulted
in massive airways inflammation with eosinophils and
lymphocytes as predominant infiltrating cells.30
Blockade of IL-9 inhibited the development of airway
inflammation in a mouse model of asthma.31 In hu-
mans, a close association between the IL9 gene and
bronchial hyperresponsiveness has been sug-
gested.32 Collectively, IL-9 may play an important role
in the pathogenesis of asthma and the potential of
eosinophils to produce IL-9 adds another mechanism
that underlie exacerbating nature of Th2-type inflam-
mation.
Environmental allergens including house dust
mites, fungi, and pollens contain various kinds of pro-
teases and it has been demonstrated that these pro-
teases directly cause activation of epithelial cells and
inflammatory cells leading to inflammatory cytokine
production24 and degradation of epithelial tight junc-
tions facilitating further allergen entry33. Thus, the
proteolytic activities characterize the pathogenic na-
ture of the allergen molecules independent of their
IgE-binding epitopes. HDM, the most common aller-
gen in Japan and other area of the world with warm
and humid climate, contains cysteine proteases and
serine proteases as well as a number of other unchar-
acterized proteases. Der p 1 and Der f 1, the major al-
lergens in HDM, are cysteine proteases and Der p 3,
Der f 3, Der p 9, and Der f 9 are serine proteases.33-36
Proteases stimulate cells via PARs, 7-transmembrane
G protein-coupled receptors. They cleave the amino
acids at a specific site of the extracellular N-terminus
of the PARs to expose a new N-terminal ligand do-
HDM Induces IL-9 from Eosinophils
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Fig. 4 IL-9 gene expression from eosinophils cultured with HDM extract pretreated at 
37°C for 30 min with AEBSF, a serine protease inhibitor, or E-64, a cysteine protease 
inhibitor. The data represent geometric means of fold changes in gene expression. (n＝3).
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main that binds to another site on the same molecule,
thereby activating the receptor. Four PARs have been
identified and amino acid sequences of each cleavage
site is specific for the particular PAR. Serine pro-
teases are PAR-2 agonists and we speculate that
HDM extract stimulated eosinophils to produce IL-9
via PAR-2 because a serine protease inhibitor, not a
cysteine protease inhibitor, blocked the reaction al-
though the results presented here were still insuffi-
cient to prove PAR-2-mediated IL-9 production.
We also examined the possibility that HDM-
induced IL-9 production from eosinophils was IgE-
mediated. Eosinophils express low affinity IgE recep-
tors, CD23, and may express high affinity Fc epsilon
receptors37,38 as well. If the latter is the case, isolated
eosinophils from peripheral blood of HDM-sensitized
individuals have membrane-bound HDM-specific IgE
antibody and have potentials to be activated upon
binding of IgE to the allergen. We found, however,
that HDM induced the activation was independent of
specific IgE to HDM. We also confirmed that that ef-
fect was not from contaminated LPS in HDM extract
because LPS did not induce IL-9 production even in
the presence of the serum.
In the present experiments, we employed the con-
centrations of HDM and LPS based on a previous
study in which the ability of various allergens to
cause eosinophil activation and chemotaxis in vitro
was investigated.15 One drawback of our study is that
the concentration of HDM used in the experiments
was rather high and we did not find significant pro-
duction of IL-9 on stimulation with lower concentra-
tions of HDM (data not shown) and the present find-
ings may not be relevant to clinical situations. How-
ever, exposure levels of HDM vary widely39 and ac-
tual concentrations found in the airways are not
known. Alternatively, our experimental model may
represent other PAR-2 and PAR-2 agonist interactions
such as tryptase from mast cells.24
In summary, we have shown that eosinophils are
capable of interacting with HDM and producing IL-9.
These findings suggest that eosinophils may play a
role in innate immunity. When eosinophils encounter
with an allergen that has serine-specific enzymaic ac-
tivity, they may promote Th2-type immune response
by producing IL-9.
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